$NNDM

Nano Dimension Ltd.

CIK:0001643303|SEC Filings

CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenue	$ 28,963	$ 25,837	$ 58,688	$ 40,238
Total cost of revenue	15,669	18,794	33,267	27,354
Gross profit	13,294	7,043	25,421	12,884
Operating expenses:
Research and development	5,785	8,114	13,989	14,058
Sales and marketing	8,405	9,907	18,097	15,551
General and administrative	12,912	22,189	28,121	27,856
Restructuring costs	6,764	3,767	9,891	4,947
Desktop Metal litigation	0	3,246	0	31,315
Impairment losses	0	1,456	40,388	2,685
Operating loss	(20,572)	(41,636)	(85,065)	(83,528)
Gain (loss) on investment in marketable equity securities	7,272	16,287	(1,163)	25,013
Other expense, net	(8)	(56)	(8)	(56)
Finance income	6,901	14,353	10,413	23,673
Finance expense	(247)	(234)	(493)	(1,913)
Loss before income taxes	(6,654)	(11,286)	(76,316)	(36,811)
Income tax expense	(150)	(76)	(150)	(99)
Net loss from continuing operations	(6,804)	(11,362)	(76,466)	(36,910)
Net loss from discontinued operations, net of income tax of nil	0	(169,761)	0	(169,761)
Net loss	(6,804)	(181,123)	(76,466)	(206,671)
Less: Comprehensive loss attributable to non-controlling interests	0	(87)	0	(323)
Net loss attributable to common shareholders	$ (6,804)	$ (181,036)	$ (76,466)	$ (206,348)
Net loss per common share:
Net loss attributable to common shareholders_Basic	$ (0.03)	$ (0.83)	$ (0.37)	$ (0.95)
Continuing operations - diluted	(0.03)	(0.05)	(0.37)	(0.17)
Continuing operations - basic	(0.03)	(0.05)	(0.37)	(0.17)
Net loss attributable to common shareholders_Diluted	(0.03)	(0.83)	(0.37)	(0.95)
Discontinued operations - basic	0	(0.78)	0	(0.78)
Discontinued operations - diluted	$ 0	$ (0.78)	$ 0	$ (0.78)
Weighted-average shares outstanding - Basic	209,342	217,338	208,671	217,057
Weighted-average shares outstanding - Diluted	209,342	217,338	208,671	217,057
Other comprehensive income (loss):
Foreign currency translation adjustment	$ 174	$ 1,085	$ 367	$ 1,678
Remeasurement of pension and post-employment benefit plans, net of tax	654	0	654	0
Comprehensive loss	(5,976)	(180,038)	(75,445)	(204,993)
Less: Comprehensive loss attributable to non-controlling interests	0	(99)	0	(224)
Comprehensive loss attributable to common shareholders	(5,976)	(179,939)	(75,445)	(204,769)
Product
Revenue	23,981	20,064	46,912	31,743
Total cost of revenue	13,186	16,410	27,408	23,491
Service
Revenue	4,982	5,773	11,776	8,495
Total cost of revenue	$ 2,483	$ 2,384	$ 5,859	$ 3,863

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flow from operating activities
Net loss	$ (76,466)	$ (36,910)
Adjustments:
Depreciation, amortization and non-cash lease interest	5,978	8,282
Impairment losses	40,388	2,685
Changes in fair value of equity securities	1,163	(25,013)
Loss from deconsolidation of subsidiaries	0	1,666
Loss from sale of business assets	1,314	0
Share-based compensation expense	3,798	1,644
Share-based settlement payment	1,215
Changes in assets and liabilities:
(Increase) decrease in inventory	(426)	3,203
(Increase) in other current assets	(1,237)	(772)
Decrease (increase) in trade receivables	2,534	(914)
Decrease in other payables	(3,308)	(7,219)
(Decrease) increase in employee benefits	(417)	77
Increase in trade payables	(1,811)	6,044
Other	(3,678)	(3,367)
Net cash used in operating activities	(30,953)	(50,594)
Cash flow relating to investing activities
Change in bank deposits	168,756	190,466
Purchase of property plant and equipment	(213)	(461)
Acquisition of subsidiaries, net of cash acquired	0	(267,806)
Deconsolidation of subsidiaries	0	(476)
Proceeds from sale of AME assets	2,000	0
Net cash provided by (used in) investing activities	170,543	(78,277)
Cash flow relating to financing activities
Repayment long-term bank debt	(81)	(72)
Net cash used in financing activities	(81)	(72)
Cash flow relating to discontinued operations
Net cash used in operating activities	0	(15,733)
Net cash used in investing activities	0	(437)
Net cash provided by financing activities	0	10,009
Net cash used in discontinued operations	0	(6,161)
Increase (decrease) in cash, cash equivalents and restricted cash	139,509	(135,104)
Effect of exchange rate fluctuations on cash	4,382	2,856
Cash, cash equivalents and restricted cash at beginning of the period	206,405	318,474
Cash, cash equivalents and restricted cash at end of the period	350,296	186,226
Supplemental disclosures of cash flow information
Cash and cash equivalents	349,108	184,545
Restricted cash in restricted deposits, current	383	60
Restricted cash in restricted deposits, non-current	805	1,621
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows	350,296	186,226
Non-cash operating and investing activity
Lease liabilities arising from obtaining right-of-use assets	0	119
Non-cash investing and financing activity
Share issuance as part of settlement	1,215	0
Fair value of contingent consideration (earnout) received in connection with sale of business assets	2,933	0
Acquisition replacement awards for pre-combination service	0	2,054
Income taxes paid during the year	$ 0	$ 48

CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 349,108	$ 204,672
Bank deposits	0	168,997
Marketable equity securities	82,990	84,154
Restricted bank deposits	383	123
Trade receivables, net of allowance for doubtful accounts ($950 and $861, respectively)	23,309	26,047
Inventory	28,253	32,878
Other current assets	13,085	8,938
Total current assets	497,128	525,809
Restricted bank deposits	805	1,610
Property, plant and equipment, net	19,521	24,840
Operating lease right-of-use assets	19,752	23,789
Deferred tax assets	424	424
Goodwill	0	40,388
Intangible assets, net	17,494	19,434
Other assets	1,646	1,930
Total assets	556,770	638,224
Current liabilities:
Trade payables	10,137	11,999
Accrued liabilities	18,722	19,514
Deferred Revenue	10,398	11,873
Current portion of lease liability	7,216	8,923
Current portion of bank loan	155	158
Total current liabilities	46,628	52,467
Employee benefits	2,607	3,697
Operating lease right-of-use liabilities	19,802	23,323
Bank loan	77	158
Long-term settlement payable	3,273	2,974
Long-term deferred revenue	2,893	3,617
Total liabilities	75,280	86,236
Commitments and contingencies (Note 12)
Equity:
Share capital of NIS 5 par value each; 500,000,000 ordinary shares authorized; 210,589,406 and 206,811,875 shares outstanding as of June 30, 2026 and December 31, 2025, respectively, and 283,084,053 and 279,306,522 shares issued as of June 30, 2026 and December 31, 2025, respectively.	423,305	417,084
Additional paid-in capital	1,296,049	1,297,323
Treasury stock	(192,507)	(192,507)
Accumulated other comprehensive income	2,069	1,048
Accumulated Loss	(1,047,426)	(970,960)
Total equity	481,490	551,988
Total liabilities and equity	$ 556,770	$ 638,224